Our Approach to a Diagnosis
The MNG neurobehavioral disorder portfolio encompasses a variety of rare genetic neurological disorders, including those related to cognition, neurodevelopment, and neurodegeneration. In many cases, neurobehavioral diseases can be categorized in multiple or all the sub-categories. Due to the complex and diverse presentation of these neurological diseases, our diagnostic approach is to offer both comprehensive panels with many clinically relevant genes as well as more focused panels designed around a well-characterized and distinct phenotype.
Neurobehavioral Disorder Tests We Offer
Intellectual Disability Panel Comparison
|Company||# of Genes||# of Known Pathogenic Variants||TAT||Del/Dup Included||STAT Available|
|Fulgent||495||14,917||21-35 Days||add on|
White Matter Disorders
For disorders affecting white matter, we offer the Comprehensive Leukodystrophy panel, which includes complimentary mitochondrial genome sequencing with deletion analysis. Panels focused on Vanishing White Matter disease, Non-Mitochondrial Leukodystrophy, and Mitochondrial Leukodystrophy are also available.
MNG Laboratories is committed to a patient-centered testing menu, high-quality diagnostics, and first-in-class reporting driven by our Genome MaNaGer® analysis pipeline. Our Neurogenetic Answers™ reporting process helps us stay at the forefront of the evolving genetics field with our regularly-updated NGS panels. Our team-based approach to variant assessment ensures we provide you with the variants that cause or are likely to cause disease and keep the number of variants of unknown significance to a minimum. Our comprehensive approach to diagnostics is accompanied by a team of customer support and scientific personnel available to answer your questions regarding our process, technology, and reports.